Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-13 Sale | 2024-06-17 6:42 pm | uniQure N.V. | QURE | Jacques Rachelle Suzanne Director | 2,221 | $5.14 | $11,416 | 14,408 (Direct) | View |
2023-06-16 Sale | 2023-06-20 5:33 pm | uniQure N.V. | QURE | Jacques Rachelle Suzanne Director | 2,301 | $18.76 | $43,167 | 33,689 (Direct) | View |
2023-02-27 Sale | 2023-03-01 4:11 pm | uniQure N.V. | QURE | Jacques Rachelle Suzanne Director | 384 | $20.02 | $7,688 | 10,230 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-19 Option Award | 2024-06-21 4:57 pm | N/A 2034-06-19 | uniQure N.V. | QURE | Jacques Rachelle Suzanne Director | 23,920 | $0 | 38,328 (Direct) | View |
2024-05-30 Option Award | 2024-06-03 4:29 pm | N/A N/A | Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director | 2,783 | $0 | 2,783 (Direct) | View |
2024-05-16 Option Award | 2024-05-20 4:58 pm | N/A 2034-05-16 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director | 2,783 | $0 | 2,783 (Direct) | View |
2024-04-26 Option Award | 2024-04-30 9:45 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Jacques Rachelle Suzanne Chief Executive Officer | 479,569,892 | $0 | 1,018,027,792 (Direct) | View |
Ownership | 2024-01-02 8:06 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Jacques Rachelle Suzanne Chief Executive Officer | 0 | $0 | 928,545,300 (Direct) | View |
2023-06-13 Option Award | 2023-06-20 5:33 pm | N/A 2033-06-13 | uniQure N.V. | QURE | Jacques Rachelle Suzanne Director | 25,760 | $0 | 33,689 (Direct) | View |
2023-05-18 Option Award | 2023-05-22 4:27 pm | N/A 2033-05-18 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director | 5,300 | $0 | 5,300 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 5:03 pm | N/A 2032-06-15 | uniQure N.V. | QURE | Jacques Rachelle Suzanne Director | 26,890 | $0 | 28,424 (Direct) | View |
2022-05-18 Option Award | 2022-05-19 2:41 pm | N/A 2032-05-18 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director | 79,600 | $0 | 79,600 (Direct) | View |
2022-02-24 Option Award | 2022-02-28 6:10 pm | N/A 2032-02-24 | uniQure N.V. | QURE | Jacques Rachelle Suzanne Director | 4,179 | $0 | 4,179 (Direct) | View |
2021-10-21 Option Award | 2021-10-22 8:09 pm | N/A 2031-10-21 | uniQure N.V. | QURE | Jacques Rachelle Suzanne Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-06-17 Option Award | 2021-06-17 4:42 pm | N/A 2031-06-17 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director | 116,400 | $0 | 116,400 (Direct) | View |
2021-03-15 Disposition | 2021-03-15 09:15 am | N/A 2030-06-18 | Viela Bio Inc. | VIE | Jacques Rachelle Suzanne Director | 22,074 | $0 | 0 (Direct) | View |
2020-06-19 Option Award(A) | 2020-06-24 4:47 pm | N/A 2030-06-18 | Viela Bio Inc. | VIE | Jacques Rachelle Suzanne Director | 22,074 | $0 | 22,074 (Direct) | View |
2020-06-19 Option Award | 2020-06-23 4:41 pm | N/A 2030-06-19 | Viela Bio Inc. | VIE | Jacques Rachelle Suzanne Director | 14,716 | $0 | 14,716 (Direct) | View |
2020-05-20 Option Award | 2020-05-22 3:00 pm | N/A 2030-05-20 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director | 40,500 | $0 | 40,500 (Direct) | View |